Principal Financial Group Inc. Grows Holdings in Acadia Healthcare Company, Inc. $ACHC

Principal Financial Group Inc. grew its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 112.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 442,943 shares of the company’s stock after purchasing an additional 234,107 shares during the quarter. Principal Financial Group Inc. owned approximately 0.48% of Acadia Healthcare worth $10,967,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the stock. Thrivent Financial for Lutherans boosted its position in Acadia Healthcare by 207.2% in the 3rd quarter. Thrivent Financial for Lutherans now owns 66,622 shares of the company’s stock valued at $1,650,000 after buying an additional 44,932 shares during the period. Vanguard Personalized Indexing Management LLC raised its stake in shares of Acadia Healthcare by 18.0% during the third quarter. Vanguard Personalized Indexing Management LLC now owns 20,008 shares of the company’s stock valued at $495,000 after acquiring an additional 3,055 shares in the last quarter. First Citizens Bank & Trust Co. boosted its holdings in shares of Acadia Healthcare by 164.1% in the third quarter. First Citizens Bank & Trust Co. now owns 59,123 shares of the company’s stock valued at $1,464,000 after purchasing an additional 36,733 shares during the period. CIBC Asset Management Inc bought a new position in Acadia Healthcare in the third quarter worth approximately $214,000. Finally, ARGA Investment Management LP purchased a new position in Acadia Healthcare during the 3rd quarter worth $1,090,000.

Acadia Healthcare Stock Up 13.7%

Shares of Acadia Healthcare stock opened at $15.53 on Thursday. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 0.73. The company has a market cap of $1.43 billion, a P/E ratio of 13.27, a PEG ratio of 3.89 and a beta of 0.89. The firm’s 50 day moving average price is $13.92 and its 200-day moving average price is $18.78. Acadia Healthcare Company, Inc. has a 52-week low of $11.43 and a 52-week high of $42.85.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. Jefferies Financial Group downgraded Acadia Healthcare to a “hold” rating in a research report on Thursday, January 22nd. Royal Bank Of Canada dropped their target price on shares of Acadia Healthcare from $19.00 to $17.00 and set an “outperform” rating on the stock in a report on Wednesday, January 14th. UBS Group reduced their price target on shares of Acadia Healthcare from $28.00 to $24.00 and set a “buy” rating for the company in a report on Wednesday, December 3rd. Cantor Fitzgerald set a $17.00 price target on shares of Acadia Healthcare in a research report on Wednesday, December 3rd. Finally, Leerink Partners lowered shares of Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 3rd. Six research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Acadia Healthcare presently has a consensus rating of “Hold” and a consensus price target of $18.62.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.